These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 33859780)

  • 1. Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis.
    Liu L; Geng H; Mei C; Chen L
    Oxid Med Cell Longev; 2021; 2021():6661534. PubMed ID: 33859780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways.
    Huang Y; Chen J; Yang S; Tan T; Wang N; Wang Y; Zhang L; Yang C; Huang H; Luo J; Luo X
    Drug Des Devel Ther; 2020; 14():4625-4637. PubMed ID: 33154629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression.
    Aoki Y; Kubota Y; Masaki N; Obara K; Tome Y; Bouvet M; Nishida K; Hoffman RM
    Anticancer Res; 2024 Jul; 44(7):2787-2792. PubMed ID: 38925854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts.
    Wang Y; Deng X; Yu C; Zhao G; Zhou J; Zhang G; Li M; Jiang D; Quan Z; Zhang Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):251. PubMed ID: 30326933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Sun H; Yin M; Qian W; Yin H
    Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
    Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
    Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 9-O-monoethyl succinate berberine effectively blocks the PI3K/AKT signaling pathway by targeting Wnt5a protein in inhibiting osteosarcoma growth.
    Wang Y; Hong J; Ge S; Wang T; Mei Z; He M; Liu Y; Fang J; Liu C; Yang L; Yuan Y
    Phytomedicine; 2024 Sep; 132():155430. PubMed ID: 39047413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway.
    Da W; Tao L; Zhu Y
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells.
    Songyang Y; Song T; Shi Z; Li W; Yang S; Li D
    Gene; 2021 Feb; 768():145309. PubMed ID: 33197518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition.
    Liao YX; Lv JY; Zhou ZF; Xu TY; Yang D; Gao QM; Fan L; Li GD; Yu HY; Liu KY
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34080667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth.
    Sun F; Zhang Y; Xu L; Li S; Chen X; Zhang L; Wu Y; Li J
    Oncol Res; 2018 May; 26(4):655-664. PubMed ID: 29191257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma.
    Zhong B; Shi D; Wu F; Wang S; Hu H; Cheng C; Qing X; Huang X; Luo X; Zhang Z; Shao Z
    Cell Death Dis; 2019 Sep; 10(10):687. PubMed ID: 31534119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway.
    Zhang P; Zhao S; Lu X; Shi Z; Liu H; Zhu B
    Gene; 2020 Jun; 745():144623. PubMed ID: 32222530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.
    Yamakawa Y; Tazawa H; Hasei J; Osaki S; Omori T; Sugiu K; Komatsubara T; Uotani K; Fujiwara T; Yoshida A; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
    Cancer Sci; 2017 Sep; 108(9):1870-1880. PubMed ID: 28685948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling.
    Huang Z; Huang Y; He H; Ni J
    Mol Med Rep; 2015 Sep; 12(3):3916-3922. PubMed ID: 26017117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model.
    Qiao H; Wang TY; Yu ZF; Han XG; Liu XQ; Wang YG; Fan QM; Qin A; Tang TT
    Cell Death Dis; 2016 Feb; 7(2):e2094. PubMed ID: 26866274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma.
    Gobin B; Huin MB; Lamoureux F; Ory B; Charrier C; Lanel R; Battaglia S; Redini F; Lezot F; Blanchard F; Heymann D
    Int J Cancer; 2015 Feb; 136(4):784-96. PubMed ID: 24961790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.